Get started
Award

メトホルミンによるがん幹細胞マーカーｃｄ１３３発現抑制機構の解明

Description: Principal Investigator：前原 経, Project Period (FY)：2017-04-26 – 2019-03-31, Research Category：Grant-in-Aid for JSPS Fellows, Section：国内, Research Field：Biological pharmacy
Amount: ¥1,700,000
Funding type: fellowship
Funder scheme: Grant-in-Aid for JSPS Fellows
Start date: 2017-04-26
End date: 2019-03-31
Funded outputs count: 8
Funder award ID: 17J00434
OpenAlex ID: G4748199771
Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines
2019 · Osamu Maehara, Shunsuke Ohnishi, et al. · Neoplasia · 44
PDF
Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats
2018 · Masatsugu Ohara, Shunsuke Ohnishi, et al. · Stem Cells International · 145
PDF
Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis
2018 · Naoki Kawagishi, Goki Suda, et al. · PLoS ONE · 50
PDF
L‐Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis
2018 · Masatsugu Ohara, Koji Ogawa, et al. · Hepatology Communications · 93
PDF
Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats
2018 · Masatsugu Ohara, Shunsuke Ohnishi, et al. · Frontiers in Pharmacology · 23
PDF
Fibroblast growth factor-2–mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma
2017 · Osamu Maehara, Goki Suda, et al. · Carcinogenesis · 91
PDF
Comparing the risk of hepatitis B virus reactivation between direct‐acting antiviral therapies and interferon‐based therapies for hepatitis C
2017 · N. Kawagishi, G. Suda, et al. · Journal of Viral Hepatitis · 48
Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection
2017 · Naoki Kawagishi, Goki Suda, et al. · Journal of Hepatology · 24
Year
Topic